<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl" type="text/xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="7d7eab12-f721-4092-8c18-7100544ade2b"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5%<br/>(Sterile)<br/>Rx only</title>
   <effectiveTime value="20250523"/>
   <setId root="3419104b-e847-492f-a541-a810a116c408"/>
   <versionNumber value="4"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id extension="080268943" root="1.3.6.1.4.1.519.1"/>
            <name>Lifestar Pharma LLC</name>
            <assignedEntity>
               <assignedOrganization>
                  <id extension="915834068" root="1.3.6.1.4.1.519.1"/>
                  <name>Mankind Pharma Limited</name>
                  <assignedEntity>
                     <assignedOrganization>
                        <id extension="916512493" root="1.3.6.1.4.1.519.1"/>
                        <name>Mankind Pharma Limited</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C43360" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MANUFACTURE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="70756-193" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C25391" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANALYSIS"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="70756-193" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84731" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="PACK"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="70756-193" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="b2e78c59-58c0-48e3-b4d1-427c095f1af3"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL Product Data Elements Section"/>
               <effectiveTime value="20250523"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="70756-193" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Proparacaine hydrochloride</name>
                        <formCode code="C60992" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SOLUTION/ DROPS"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Proparacaine hydrochloride</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator value="5" unit="mg"/>
                              <denominator value="1" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="U96OL57GOY" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>PROPARACAINE HYDROCHLORIDE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="B4OB0JHI1X" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>PROPARACAINE</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="PDC6A3C0OX" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>GLYCERIN</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="3X4P6271OX" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>CHLOROBUTANOL HEMIHYDRATE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="F5UM2KM3W7" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>BENZALKONIUM CHLORIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="QTT17582CB" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>HYDROCHLORIC ACID</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="55X04QC32I" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM HYDROXIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="15" unit="mL"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43171" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE, DROPPER"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="1" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="70756-193-35" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20250521"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic classCode="OBS">
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C102842" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 9: Other Type of Part 3 Combination Product (e.g., Drug/Device/Biological Product)" xsi:type="CE"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="ANDA219136" root="2.16.840.1.113883.3.150"/>
                           <code code="C73584" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20250521"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38287" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="OPHTHALMIC"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="ID1">
               <id root="9bdb939d-1d3e-4f59-84cf-6ad0a91bdfcb"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>DESCRIPTION</title>
               <text>
                  <paragraph ID="ID2">Proparacaine hydrochloride ophthalmic solution USP is a local anesthetic for ophthalmic instillation. Each mL of sterile aqueous solution contains 5 mg proparacaine hydrochloride with glycerin as a stabilizer, sodium hydroxide or hydrochloric acid to adjust the pH, and 2 mg chlorobutanol (chloral derivative) and benzalkonium chloride as antimicrobial preservatives. At the time of manufacture, the air in the container is replaced by nitrogen.</paragraph>
                  <paragraph>Proparacaine hydrochloride is designated chemically as 2-(Diethylamino) ethyl 3-amino-4- propoxybenzoate monohydrochloride.</paragraph>
                  <paragraph>Graphic formula:</paragraph>
                  <renderMultiMedia referencedObject="MM1"/>
               </text>
               <effectiveTime value="20250523"/>
               <component>
                  <observationMedia ID="MM1">
                     <text>Proparacaine Hydrochloride molecular structure representation</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="7d7eab12-f721-4092-8c18-7100544ade2b-01.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID6">
               <id root="ccc0bc9b-fe22-45f8-ada3-0b533314fc08"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>CLINICAL PHARMACOLOGY</title>
               <text>
                  <paragraph ID="ID7">Proparacaine hydrochloride ophthalmic solution is a rapid acting local anesthetic suitable for ophthalmic use. With a single drop, the onset of anesthesia occurs in approximately 13 seconds and persists for 15 minutes or longer.</paragraph>
                  <paragraph>The main site of anesthetic action is the nerve cell membrane where proparacaine interferes with the large transient increase in the membrane permeability to sodium ions that is normally produced by a slight depolarization of the membrane. As the anesthetic action progressively develops in a nerve, the threshold for electrical stimulation gradually increases and the safety factor for conduction decreases; when this action is sufficiently well developed, block of conduction is produced.</paragraph>
                  <paragraph>The exact mechanism whereby proparacaine and other local anesthetics influence the permeability of the cell membrane is unknown; however, several studies indicate that local anesthetics may limit sodium ion permeability by closing the pores through which the ions migrate in the lipid layer of the nerve cell membrane. This limitation prevents the fundamental change necessary for the generation of the action potential.</paragraph>
               </text>
               <effectiveTime value="20240708"/>
            </section>
         </component>
         <component>
            <section ID="ID8">
               <id root="0355b5e0-ef4d-4dd8-bb66-c76741d2909a"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>INDICATIONS AND USAGE</title>
               <text>
                  <paragraph ID="ID9">Proparacaine hydrochloride ophthalmic solution is indicated for topical anesthesia in ophthalmic practice. Representative ophthalmic procedures in which the preparation provides good local anesthesia include measurement of intraocular pressure (tonometry), removal of foreign bodies and sutures from the cornea, conjunctival scraping in diagnosis and gonioscopic examination; it is also indicated for use as a topical anesthetic prior to surgical operations such as cataract extraction.</paragraph>
               </text>
               <effectiveTime value="20240708"/>
            </section>
         </component>
         <component>
            <section ID="ID10">
               <id root="7796a508-1e09-44dc-8485-0d3f371427db"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>CONTRAINDICATIONS</title>
               <text>
                  <paragraph ID="ID16">This preparation is contraindicated in patients with known hypersensitivity to any component of the solution.</paragraph>
               </text>
               <effectiveTime value="20240708"/>
            </section>
         </component>
         <component>
            <section ID="ID11">
               <id root="2a5f8b76-e45a-4fcf-98a7-e36e1b91d930"/>
               <code code="34071-1" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS SECTION"/>
               <title>WARNINGS</title>
               <text>
                  <paragraph ID="ID17">For topical ophthalmic use only.</paragraph>
                  <paragraph>Prolonged use of a topical ocular anesthetic may produce permanent corneal opacification with accompanying loss of vision.</paragraph>
                  <paragraph>Proparacaine ophthalmic solution is indicated for administration under the direct supervision of a healthcare provider. Proparacaine ophthalmic solution is not intended for patient self-administration.</paragraph>
               </text>
               <effectiveTime value="20240708"/>
            </section>
         </component>
         <component>
            <section ID="ID12">
               <id root="85863f87-cb26-4dac-845e-ef6c13c66f14"/>
               <code code="42232-9" codeSystem="2.16.840.1.113883.6.1" displayName="PRECAUTIONS SECTION"/>
               <title>PRECAUTIONS</title>
               <effectiveTime value="20240708"/>
               <component>
                  <section ID="ID37">
                     <id root="2c501450-ca6f-443c-b990-e17c7b76d5cf"/>
                     <title>General</title>
                     <text>
                        <paragraph ID="ID38">Proparacaine should be used cautiously and sparingly in patients with known allergies, cardiac disease, or hyperthyroidism. The long-term toxicity of proparacaine is unknown; prolonged use may possibly delay wound healing. Although exceedingly rare with ophthalmic application of local anesthetics, it should be borne in mind that systemic toxicity (manifested by central nervous system stimulation followed by depression) may occur. Protection of the eye from irritating chemicals, foreign bodies and rubbing during the period of anesthesia is very important. Tonometers soaked in sterilizing or detergent solutions should be thoroughly rinsed with sterile distilled water prior to use. Patients should be advised to avoid touching the eye until the anesthesia has worn off.</paragraph>
                     </text>
                     <effectiveTime value="20240708"/>
                  </section>
               </component>
               <component>
                  <section ID="ID18">
                     <id root="73490957-03f3-403f-a58d-729841aa6382"/>
                     <title>Carcinogenesis, Mutagenesis, Impairment of Fertility</title>
                     <text>
                        <paragraph ID="ID23">Long-term studies in animals have not been performed to evaluate carcinogenic potential, mutagenicity or possible impairment of fertility in males or females.</paragraph>
                     </text>
                     <effectiveTime value="20240708"/>
                  </section>
               </component>
               <component>
                  <section ID="ID19">
                     <id root="ad538933-20e3-4fb4-9a16-e587afca12fa"/>
                     <title>Pregnancy</title>
                     <text>
                        <paragraph ID="ID24">Animal reproduction studies have not been conducted with proparacaine hydrochloride ophthalmic solution USP, 0.5%. It is also not known whether proparacaine hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Proparacaine hydrochloride should be administered to a pregnant woman only if clearly needed.</paragraph>
                     </text>
                     <effectiveTime value="20240708"/>
                  </section>
               </component>
               <component>
                  <section ID="ID20">
                     <id root="ad2d0be7-4dd1-45b3-99b3-53539c462ed0"/>
                     <title>Nursing Mothers</title>
                     <text>
                        <paragraph ID="ID25">It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when proparacaine hydrochloride is administered to a nursing woman.</paragraph>
                     </text>
                     <effectiveTime value="20240708"/>
                  </section>
               </component>
               <component>
                  <section ID="ID21">
                     <id root="c92fadf3-e785-40a6-a3ab-20dab918628e"/>
                     <title>Pediatric Use</title>
                     <text>
                        <paragraph ID="ID26">Safety and effectiveness of proparacaine hydrochloride ophthalmic solution in pediatric patients have been established. Use of proparacaine hydrochloride is supported by evidence from adequate and well-controlled studies in adults and children over the age of twelve, and safety information in neonates and other pediatric patients.</paragraph>
                     </text>
                     <effectiveTime value="20240708"/>
                  </section>
               </component>
               <component>
                  <section ID="ID22">
                     <id root="771e904d-e94a-4fb2-acb2-02e19c2c71e4"/>
                     <title>Geriatric Use</title>
                     <text>
                        <paragraph ID="ID27">No overall clinical differences in safety or effectiveness have been observed between the elderly and other adult patients.</paragraph>
                     </text>
                     <effectiveTime value="20240708"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID13">
               <id root="590ed3fc-6671-48fc-a84f-f8b13b3022db"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>ADVERSE REACTIONS</title>
               <text>
                  <paragraph ID="ID28">Pupillary dilation or cycloplegic effects have rarely been observed with proparacaine hydrochloride. The drug appears to be safe for use in patients sensitive to other local anesthetics, but local or systemic sensitivity occasionally occurs.</paragraph>
                  <paragraph>Instillation of proparacaine in the eye at recommended concentration and dosage usually produces little or no initial irritation, stinging, burning, conjunctival redness, lacrimation or increased winking. However, some local irritation and stinging may occur several hours after the instillation. Rarely, a severe, immediate-type, apparently hyperallergic corneal reaction may occur which includes acute, intense and diffuse epithelial keratitis; a gray, ground-glass appearance; sloughing of large areas of necrotic epithelium; corneal filaments and, sometimes, iritis with descemetitis. Allergic contact dermatitis with drying and fissuring of the fingertips has been reported.</paragraph>
                  <paragraph>Softening and erosion of the corneal epithelium and conjunctival congestion and hemorrhage have been reported.</paragraph>
                  <paragraph>
                     <content styleCode="bold">To report SUSPECTED ADVERSE REACTIONS, contact Lifestar Pharma LLC at 1-888-995-4337 or FDA at 1-800-FDA-1088 or <content styleCode="italics">www.fda.gov/medwatch</content>.</content>
                  </paragraph>
               </text>
               <effectiveTime value="20240708"/>
            </section>
         </component>
         <component>
            <section ID="ID14">
               <id root="f99d0a63-84bc-48b5-8cc9-4f3dfd0bc7e8"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>DOSAGE AND ADMINISTRATION</title>
               <text>
                  <paragraph ID="ID29">
                     <content styleCode="italics">Deep anesthesia as in cataract extraction:</content>
                  </paragraph>
                  <paragraph>Instill 1 drop every 5 to 10 minutes for 5 to 7 doses.</paragraph>
                  <paragraph>
                     <content styleCode="italics">Removal of sutures:</content>
                  </paragraph>
                  <paragraph>Instill 1 or 2 drops 2 or 3 minutes before removal of stitches.</paragraph>
                  <paragraph>
                     <content styleCode="italics">Removal of foreign bodies:</content>
                  </paragraph>
                  <paragraph>Instill 1 or 2 drops prior to operating.</paragraph>
                  <paragraph>
                     <content styleCode="italics">Tonometry:</content>
                  </paragraph>
                  <paragraph>Instill 1 or 2 drops immediately before measurement</paragraph>
               </text>
               <effectiveTime value="20240708"/>
            </section>
         </component>
         <component>
            <section ID="ID15">
               <id root="73020e07-eec0-4c45-a56f-051ff3dfb264"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>HOW SUPPLIED</title>
               <text>
                  <paragraph ID="ID30">Proparacaine hydrochloride ophthalmic solution USP, 0.5% is supplied in a low density polyethylene white bottle with a natural dropper tip with a white screw cap in the following size: </paragraph>
                  <paragraph>NDC 70756-193-35 15 mL bottle in carton.</paragraph>
                  <paragraph ID="ID31">
                     <content styleCode="bold">Storage:</content>
                  </paragraph>
                  <paragraph>   Refrigerate at 2°C to 8° C (36°F to 46°F). Keep bottle tightly closed. Store bottles in carton until empty to protect from light. If solution shows more than a faint yellow color, it should not be used.</paragraph>
                  <paragraph>
                     <content styleCode="bold">DO NOT USE IF TAMPER-EVIDENT SEAL IS BROKEN OR MISSING.</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Keep out of reach of children.</content>
                  </paragraph>
                  <paragraph>Manufactured for:</paragraph>
                  <paragraph>
                     <content styleCode="bold">Lifestar Pharma LLC</content> </paragraph>
                  <paragraph>1200 MacArthur Blvd.</paragraph>
                  <paragraph>Mahwah, NJ 07430 USA </paragraph>
                  <paragraph>
                     <content styleCode="bold">Product of Switzerland</content>
                  </paragraph>
                  <paragraph>Revised: July 2024, V-02</paragraph>
               </text>
               <effectiveTime value="20250523"/>
            </section>
         </component>
         <component>
            <section ID="ID32">
               <id root="d88244b7-2e5a-46f5-912a-be18ff117c59"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PACKAGE LABEL.PRINCIPAL DISPLAY PANEL</title>
               <text>
                  <paragraph ID="ID33">
                     <content styleCode="bold">NDC 70756-193-35</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Proparacaine Hydrochloride Ophthalmic Solution, USP</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">0.5%</content>
                  </paragraph>
                  <paragraph>(Sterile)</paragraph>
                  <paragraph>
                     <content styleCode="bold">For eye use only</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Not for injection</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">15 mL</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Rx only</content>
                  </paragraph>
                  <renderMultiMedia referencedObject="MM2"/>
                  <paragraph ID="ID35">
                     <content styleCode="bold">NDC 70756-193-35</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Proparacaine Hydrochloride Ophthalmic Solution, USP</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">0.5%</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">For eye use only</content>
                  </paragraph>
                  <paragraph>(Sterile)</paragraph>
                  <paragraph>
                     <content styleCode="bold">Not for injection</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">15 mL </content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Rx only</content>
                  </paragraph>
                  <renderMultiMedia referencedObject="MM3"/>
               </text>
               <effectiveTime value="20250523"/>
               <component>
                  <observationMedia ID="MM2">
                     <text>label</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="7d7eab12-f721-4092-8c18-7100544ade2b-02.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM3">
                     <text>carton</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="7d7eab12-f721-4092-8c18-7100544ade2b-03.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>